Wine Polyphenols and Neurodegenerative Diseases: An Update on the Molecular Mechanisms Underpinning Their Protective Effects

Alzheimer’s and Parkinson’s diseases are the most common age-related and predominantly idiopathic neurodegenerative disorders of unknown pathogenesis. Although there are both clinical and neuropathological features of these diseases that are different, they also share some common aetiologies, such as protein aggregation, mitochondrial dysfunction, oxidative stress, and neuroinflammation. Epidemiological, in vitro and in vivo evidences suggest an inverse correlation between wine consumption and the incidence of neurodegenerative disorders. Wine benefits are, in large part, attributable to the intake of specific polyphenols, which mediate cell function under both normal and pathological conditions. In this review, we aim to provide an overview of the role that wine consumption plays in delaying neurodegenerative disorders. We discuss animal and in vitro studies in support of these actions and we consider how their biological mechanisms at the cellular level may underpin their physiological effects. Together, these data indicate that polyphenols present in wine may hold neuroprotective potential in delaying the onset of neurodegenerative disorders.

[1]  M. Zahran,et al.  Novel multi-target compounds in the quest for new chemotherapies against Alzheimer's disease: An experimental and theoretical study. , 2018, Bioorganic & medicinal chemistry.

[2]  M. Prata-Sena,et al.  The terroir of Port wine: Two hundred and sixty years of history. , 2018, Food chemistry.

[3]  M. Pallàs,et al.  Resveratrol Induces Brain Resilience Against Alzheimer Neurodegeneration Through Proteostasis Enhancement , 2018, Molecular Neurobiology.

[4]  E. Sigurdsson,et al.  Tau-targeting therapies for Alzheimer disease , 2018, Nature Reviews Neurology.

[5]  F. Stefanello,et al.  Anthocyanins as a potential pharmacological agent to manage memory deficit, oxidative stress and alterations in ion pump activity induced by experimental sporadic dementia of Alzheimer's type. , 2018, The Journal of nutritional biochemistry.

[6]  T. Matsumiya,et al.  Gnetin C, a resveratrol dimer, reduces amyloid-β 1-42 (Aβ42) production and ameliorates Aβ42-lowered cell viability in cultured SH-SY5Y human neuroblastoma cells. , 2018, Biomedical research.

[7]  Jing Zhang,et al.  Resveratrol Suppresses Rotenone‐induced Neurotoxicity Through Activation of SIRT1/Akt1 Signaling Pathway , 2018, Anatomical record.

[8]  S. Berndt,et al.  The association of lifetime alcohol use with mortality and cancer risk in older adults: A cohort study , 2018, PLoS medicine.

[9]  M. Hornberger,et al.  Impact of Flavonoids on Cellular and Molecular Mechanisms Underlying Age-Related Cognitive Decline and Neurodegeneration , 2018, Current Nutrition Reports.

[10]  A. Muthuraman,et al.  Therapeutic evaluation of solid lipid nanoparticle of quercetin in pentylenetetrazole induced cognitive impairment of zebrafish , 2018, Life sciences.

[11]  D. Lie,et al.  Insulin-like Growth Factor 1 (IGF-1) as a marker of cognitive decline in normal ageing: A review , 2018, Ageing Research Reviews.

[12]  Berislav V. Zlokovic,et al.  Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders , 2018, Nature Reviews Neurology.

[13]  M. Landgraf,et al.  Regulation of neuronal development and function by ROS , 2018, FEBS letters.

[14]  Jie Xu,et al.  Quercetin inhibits okadaic acid-induced tau protein hyperphosphorylation through the Ca2+‑calpain‑p25‑CDK5 pathway in HT22 cells. , 2017, International journal of molecular medicine.

[15]  B. Barres,et al.  Microglia and macrophages in brain homeostasis and disease , 2017, Nature Reviews Immunology.

[16]  Hee-Sun Kim,et al.  Resveratrol Ameliorates Tau Hyperphosphorylation at Ser396 Site and Oxidative Damage in Rat Hippocampal Slices Exposed to Vanadate: Implication of ERK1/2 and GSK-3β Signaling Cascades. , 2017, Journal of agricultural and food chemistry.

[17]  S. Réhman,et al.  Anthocyanin-Loaded PEG-Gold Nanoparticles Enhanced the Neuroprotection of Anthocyanins in an Aβ1–42 Mouse Model of Alzheimer’s Disease , 2016, Molecular Neurobiology.

[18]  F. Shahidi,et al.  Lipophilization of Resveratrol and Effects on Antioxidant Activities. , 2017, Journal of agricultural and food chemistry.

[19]  Jinbo Cheng,et al.  Vitamin D Combined with Resveratrol Prevents Cognitive Decline in SAMP8 Mice. , 2017, Current Alzheimer research.

[20]  Puneet Kumar,et al.  Neuroprotective potential of Quercetin in combination with piperine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity , 2017, Neural regeneration research.

[21]  Ilya Bezprozvanny,et al.  Calcium signaling and molecular mechanisms underlying neurodegenerative diseases. , 2017, Cell calcium.

[22]  M. Kawahara,et al.  Cross talk between neurometals and amyloidogenic proteins at the synapse and the pathogenesis of neurodegenerative diseases. , 2017, Metallomics : integrated biometal science.

[23]  A. Kanthasamy,et al.  Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's Disease , 2017, Journal of neurochemistry.

[24]  C. Isidoro,et al.  Resveratrol protects neuronal-like cells expressing mutant Huntingtin from dopamine toxicity by rescuing ATG4-mediated autophagosome formation , 2017, Neurochemistry International.

[25]  M. Maeda,et al.  Combination therapy with octyl gallate and ferulic acid improves cognition and neurodegeneration in a transgenic mouse model of Alzheimer's disease , 2017, The Journal of Biological Chemistry.

[26]  O. Franco,et al.  Alcoholic beverage preference and diabetes incidence across Europe: the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES) project , 2017, European Journal of Clinical Nutrition.

[27]  M. Kim,et al.  Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ1–42-induced oxidative stress , 2017, Journal of Nanobiotechnology.

[28]  R. He,et al.  Resveratrol Attenuates Formaldehyde Induced Hyperphosphorylation of Tau Protein and Cytotoxicity in N2a Cells , 2017, Frontiers in neuroscience.

[29]  F. J. Luque,et al.  Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs. , 2017, Journal of natural products.

[30]  L. Tan,et al.  Alcohol consumption and dementia risk: a dose–response meta-analysis of prospective studies , 2017, European Journal of Epidemiology.

[31]  G. Gao,et al.  Resveratrol attenuates MPP+-induced mitochondrial dysfunction and cell apoptosis via AKT/GSK-3β pathway in SN4741 cells , 2017, Neuroscience Letters.

[32]  M. Islam Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders , 2017, Neurological research.

[33]  S. Salim,et al.  Oxidative Stress and the Central Nervous System , 2017, The Journal of Pharmacology and Experimental Therapeutics.

[34]  S. Martín-Aragón,et al.  Neurohormetic responses of quercetin and rutin in a cell line over-expressing the amyloid precursor protein (APPswe cells). , 2016, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[35]  P. Mcgeer,et al.  Quercetin, not caffeine, is a major neuroprotective component in coffee , 2016, Neurobiology of Aging.

[36]  S. Kuo,et al.  Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of α-synuclein via SIRT1-deacetylated LC3. , 2016, Molecular nutrition & food research.

[37]  Siming Huang,et al.  Effects of grape seed proanthocyanidin on Alzheimer's disease in vitro and in vivo , 2016, Experimental and therapeutic medicine.

[38]  H. El-Horany,et al.  Ameliorative Effect of Quercetin on Neurochemical and Behavioral Deficits in Rotenone Rat Model of Parkinson's Disease: Modulating Autophagy (Quercetin on Experimental Parkinson's Disease) , 2016, Journal of biochemical and molecular toxicology.

[39]  Haoyue Deng,et al.  Resveratrol Attenuates Aβ25–35 Caused Neurotoxicity by Inducing Autophagy Through the TyrRS-PARP1-SIRT1 Signaling Pathway , 2016, Neurochemical Research.

[40]  M. Elbatsh,et al.  Modulatory effects of resveratrol on endoplasmic reticulum stress-associated apoptosis and oxido-inflammatory markers in a rat model of rotenone-induced Parkinson's disease. , 2016, Chemico-biological interactions.

[41]  Weilang Li,et al.  NAMPT protects against 6-hydroxydopamine-induced neurotoxicity in PC12 cells through modulating SIRT1 activity. , 2016, Molecular medicine reports.

[42]  Min-Ju Kim,et al.  Piceatannol, a natural analogue of resveratrol, effectively reduces beta-amyloid levels via activation of alpha-secretase and matrix metalloproteinase-9 , 2016 .

[43]  J. Hardy,et al.  The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.

[44]  F. Mahn,et al.  Resveratrol reduces amyloid-beta (Aβ1–42)-induced paralysis through targeting proteostasis in an Alzheimer model of Caenorhabditis elegans , 2016, European Journal of Nutrition.

[45]  Jing Zhang,et al.  Resveratrol Protects PC12 Cell against 6-OHDA Damage via CXCR4 Signaling Pathway , 2015, Evidence-based complementary and alternative medicine : eCAM.

[46]  Jia-wei Zhou,et al.  Neuroinflammation in Parkinson’s disease and its potential as therapeutic target , 2015, Translational Neurodegeneration.

[47]  J. Blesa,et al.  Oxidative stress and Parkinson’s disease , 2015, Front. Neuroanat..

[48]  B. Jeon,et al.  The role of quercetin on the survival of neuron-like PC12 cells and the expression of α-synuclein , 2015, Neural regeneration research.

[49]  J. R. Ramírez-Pineda,et al.  The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice , 2015, Neuropharmacology.

[50]  Muralidhara,et al.  Combined Oral Supplementation of Fish Oil and Quercetin Enhances Neuroprotection in a Chronic Rotenone Rat Model: Relevance to Parkinson’s Disease , 2015, Neurochemical Research.

[51]  T. Broderick,et al.  Resveratrol protects β amyloid-induced oxidative damage and memory associated proteins in H19-7 hippocampal neuronal cells. , 2015, Current Alzheimer research.

[52]  Huaxi Xu,et al.  The Resveratrol Trimer Miyabenol C Inhibits β-Secretase Activity and β-Amyloid Generation , 2015, PloS one.

[53]  J. Richardson,et al.  Dietary (−)-epicatechin as a potent inhibitor of βγ-secretase amyloid precursor protein processing , 2015, Neurobiology of Aging.

[54]  D. Selkoe,et al.  Purification of α-Synuclein from Human Brain Reveals an Instability of Endogenous Multimers as the Protein Approaches Purity , 2014, Biochemistry.

[55]  W. V. Van Nostrand,et al.  Capping of Aβ42 Oligomers by Small Molecule Inhibitors , 2014, Biochemistry.

[56]  A. Meratan,et al.  Interaction of Aβ(25–35) fibrillation products with mitochondria: Effect of small‐molecule natural products , 2014, Biopolymers.

[57]  Byeong-Chae Kim,et al.  Effects of Flavonoid Compounds on β-amyloid-peptide-induced Neuronal Death in Cultured Mouse Cortical Neurons , 2014, Chonnam medical journal.

[58]  Vincenzo Bonifati,et al.  Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease. , 2014, Biochimica et biophysica acta.

[59]  Dong-mei Wang,et al.  Effects of Long-Term Treatment with Quercetin on Cognition and Mitochondrial Function in a Mouse Model of Alzheimer’s Disease , 2014, Neurochemical Research.

[60]  D. Eliezer,et al.  Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity , 2014, Front. Aging Neurosci..

[61]  F. Fan,et al.  Radioprotective and Antioxidant Effect of Resveratrol in Hippocampus by Activating Sirt1 , 2014, International journal of molecular sciences.

[62]  Shang-Der Chen,et al.  Resveratrol Partially Prevents Rotenone-Induced Neurotoxicity in Dopaminergic SH-SY5Y Cells through Induction of Heme Oxygenase-1 Dependent Autophagy , 2014, International journal of molecular sciences.

[63]  D. Galimberti,et al.  Immunotherapy against amyloid pathology in Alzheimer's disease , 2013, Journal of the Neurological Sciences.

[64]  G. Casadesus,et al.  Dietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8 , 2013, AGE.

[65]  G. Viana,et al.  Catechin attenuates behavioral neurotoxicity induced by 6-OHDA in rats , 2013, Pharmacology Biochemistry and Behavior.

[66]  M. Delgado,et al.  Neuroprotective Properties of Standardized Extracts of Hypericum perforatum on Rotenone Model of Parkinson's Disease. , 2013, CNS & neurological disorders drug targets.

[67]  M. Chesselet,et al.  Mitochondrial dysfunction and oxidative stress in Parkinson's disease , 2013, Progress in Neurobiology.

[68]  M. Mansouri,et al.  Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats. , 2013, Food chemistry.

[69]  S. Karuppagounder,et al.  Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson’s disease in rats , 2013, Neuroscience.

[70]  Min Zhu,et al.  Oxidized quercetin inhibits α-synuclein fibrillization. , 2013, Biochimica et biophysica acta.

[71]  R. Pi,et al.  Protective effects of caffeic acid and caffeic acid phenethyl ester against acrolein-induced neurotoxicity in HT22 mouse hippocampal cells , 2013, Neuroscience Letters.

[72]  M. Guillot-Sestier,et al.  Ferulic Acid Is a Nutraceutical β-Secretase Modulator That Improves Behavioral Impairment and Alzheimer-like Pathology in Transgenic Mice , 2013, PloS one.

[73]  Nagaraja Haleagrahara,et al.  Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats. , 2013, The Journal of toxicological sciences.

[74]  J. Simon,et al.  Identification of brain‐targeted bioactive dietary quercetin‐3‐O‐glucuronide as a novel intervention for Alzheimer's disease , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  H. Byun,et al.  β-secretase inhibitory activity of phenolic acid conjugated chitooligosaccharides , 2013, Journal of enzyme inhibition and medicinal chemistry.

[76]  A. Wimo,et al.  The global prevalence of dementia: A systematic review and metaanalysis , 2013, Alzheimer's & Dementia.

[77]  K. Shindler,et al.  SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells , 2012, Front. Cell. Neurosci..

[78]  Jiang-Ning Zhou,et al.  The binding of resveratrol to monomer and fibril amyloid beta , 2012, Neurochemistry International.

[79]  Weikai He,et al.  Resveratrol attenuates oxidative damage and ameliorates cognitive impairment in the brain of senescence-accelerated mice. , 2012, Life sciences.

[80]  M. Saraiva,et al.  Stability of the Transthyretin Molecule as a Key Factor in the Interaction with A-Beta Peptide - Relevance in Alzheimer's Disease , 2012, PloS one.

[81]  N. Belluardo,et al.  Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson’s disease , 2012, Cellular and Molecular Life Sciences.

[82]  K. Kawabata,et al.  Effect of quercetin and its glucuronide metabolite upon 6-hydorxydopamine-induced oxidative damage in Neuro-2a cells , 2012, Free radical research.

[83]  K. Lu,et al.  Resveratrol Protects Rats from Aβ-induced Neurotoxicity by the Reduction of iNOS Expression and Lipid Peroxidation , 2011, PloS one.

[84]  S. Martín-Aragón,et al.  Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells. , 2011, Life sciences.

[85]  H. Kurihara,et al.  Resveratrol improves cognitive function in mice by increasing production of insulin-like growth factor-I in the hippocampus. , 2011, The Journal of nutritional biochemistry.

[86]  N. Mitra,et al.  Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum , 2011, Neuroscience Letters.

[87]  X. Pu,et al.  Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease. , 2011, Biological & pharmaceutical bulletin.

[88]  J. Jankovic,et al.  Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson's Disease , 2011, Neurosignals.

[89]  Sanjay Kumar,et al.  Conformational transition in the substrate binding domain of β-secretase exploited by NMA and its implication in inhibitor recognition: BACE1–myricetin a case study , 2011, Neurochemistry International.

[90]  S. Ryu,et al.  In vitro BACE-1 inhibitory activity of resveratrol oligomers from the seed extract of Paeonia lactiflora. , 2011, Planta medica.

[91]  G. Yen,et al.  Protective effects of anthocyanins against amyloid β-peptide-induced damage in neuro-2A cells. , 2011, Journal of agricultural and food chemistry.

[92]  S. Lichtenthaler Alpha‐secretase in Alzheimer’s disease: molecular identity, regulation and therapeutic potential , 2011, Journal of neurochemistry.

[93]  Dong-Mei Wu,et al.  Quercetin activates AMP‐activated protein kinase by reducing PP2C expression protecting old mouse brain against high cholesterol‐induced neurotoxicity , 2010, The Journal of pathology.

[94]  F. Zhang,et al.  Resveratrol Protects Dopamine Neurons Against Lipopolysaccharide-Induced Neurotoxicity through Its Anti-Inflammatory Actions , 2010, Molecular Pharmacology.

[95]  K. Kwon,et al.  Melatonin Potentiates the Neuroprotective Properties of Resveratrol Against Beta-Amyloid-Induced Neurodegeneration by Modulating AMP-Activated Protein Kinase Pathways , 2010, Journal of clinical neurology.

[96]  Dr David Vauzour,et al.  Caffeic acid, tyrosol and p-coumaric acid are potent inhibitors of 5-S-cysteinyl-dopamine induced neurotoxicity. , 2010, Archives of biochemistry and biophysics.

[97]  S. Rajasankar,et al.  Resveratrol attenuates oxidative stress and improves behaviour in 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) challenged mice , 2010, Annals of neurosciences.

[98]  R. Koehler,et al.  Resveratrol protects against experimental stroke: Putative neuroprotective role of heme oxygenase 1 , 2010, Experimental Neurology.

[99]  Soahary Andriamanarivo,et al.  New stilbene dimers against amyloid fibril formation. , 2010, Bioorganic & medicinal chemistry letters.

[100]  J. Dordick,et al.  Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid Aβ into Off-pathway Conformers* , 2010, The Journal of Biological Chemistry.

[101]  S. Costanzo,et al.  Contemporary Reviews in Cardiovascular Medicine Cardiovascular and Overall Mortality Risk in Relation to Alcohol Consumption in Patients With Cardiovascular Disease , 2010 .

[102]  T. Ishrat,et al.  Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease , 2010, Brain Research.

[103]  M. Kobori,et al.  Autophagy impairment stimulates PS1 expression and γ-secretase activity , 2010, Autophagy.

[104]  G. Rimbach,et al.  Effect of dietary quercetin on brain quercetin levels and the expression of antioxidant and Alzheimer's disease relevant genes in mice. , 2010, Pharmacological research.

[105]  M. Jimenez-Del-Rio,et al.  The Effects of Polyphenols on Survival and Locomotor Activity in Drosophila melanogaster Exposed to Iron and Paraquat , 2010, Neurochemical Research.

[106]  J. Simon,et al.  AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism* , 2010, The Journal of Biological Chemistry.

[107]  Lijuan Sun,et al.  Grape extract protects mitochondria from oxidative damage and improves locomotor dysfunction and extends lifespan in a Drosophila Parkinson's disease model. , 2009, Rejuvenation research.

[108]  Lei Huang,et al.  Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. , 2009, Neurotoxicology.

[109]  M. Shimoji,et al.  CXCR4 and CXCL12 Expression is Increased in the Nigro-Striatal System of Parkinson’s Disease , 2009, Neurotoxicity Research.

[110]  Dagmar Verbaan,et al.  Non-motor symptoms in Parkinson's disease , 2009 .

[111]  S. Joo,et al.  Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation. , 2009, Life sciences.

[112]  M. Beal,et al.  Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease , 2009, Neurochemistry International.

[113]  S. Ryu,et al.  A new specific BACE-1 inhibitor from the stembark extract of Vitis vinifera. , 2009, Planta medica.

[114]  Qin Wu,et al.  Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. , 2008, European journal of pharmacology.

[115]  K. Vafeiadou,et al.  The neuroprotective potential of flavonoids: a multiplicity of effects , 2008, Genes & Nutrition.

[116]  F. Sallusto,et al.  Chemokines and leukocyte traffic , 2008, Nature Immunology.

[117]  A. Raasmaja,et al.  Time-dependent protective and harmful effects of quercetin on 6-OHDA-induced toxicity in neuronal SH-SY5Y cells. , 2008, Toxicology.

[118]  K. Vafeiadou,et al.  Peroxynitrite induced formation of the neurotoxins 5-S-cysteinyl-dopamine and DHBT-1: implications for Parkinson's disease and protection by polyphenols. , 2008, Archives of biochemistry and biophysics.

[119]  K. Lu,et al.  Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. , 2008, Journal of agricultural and food chemistry.

[120]  G. Bronchti,et al.  Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[121]  D. Teplow,et al.  Grape-Derived Polyphenolics Prevent Aβ Oligomerization and Attenuate Cognitive Deterioration in a Mouse Model of Alzheimer's Disease , 2008, The Journal of Neuroscience.

[122]  T. Kihara,et al.  Flavonols and flavones as BACE-1 inhibitors: structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features. , 2008, Biochimica et biophysica acta.

[123]  A. Raasmaja,et al.  Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures , 2008, Brain Research.

[124]  C. Björkelund,et al.  Alcoholic beverages and incidence of dementia: 34-year follow-up of the prospective population study of women in Goteborg. , 2007, American journal of epidemiology.

[125]  Andre Fischer,et al.  SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis , 2007, The EMBO journal.

[126]  M. Poncz,et al.  Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine , 2007, Experimental & Molecular Medicine.

[127]  J. Milbrandt,et al.  Resveratrol stimulates AMP kinase activity in neurons , 2007, Proceedings of the National Academy of Sciences.

[128]  K. Vafeiadou,et al.  Champagne wine polyphenols protect primary cortical neurons against peroxynitrite-induced injury. , 2007, Journal of agricultural and food chemistry.

[129]  Phillip Nagley,et al.  Rotenone and MPP+ preferentially redistribute apoptosis-inducing factor in apoptotic dopamine neurons , 2007, Neuroreport.

[130]  A. Akaike,et al.  Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults. , 2007, Biochemical pharmacology.

[131]  Jun Wang,et al.  Moderate consumption of Cabernet Sauvignon attenuates A� neuropathology in a mouse model of Alzheimer's disease , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[132]  Peter Davies,et al.  Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides* , 2005, Journal of Biological Chemistry.

[133]  H. Dodge,et al.  Alcohol consumption and cognitive function in late life , 2005, Neurology.

[134]  R. Torella,et al.  Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients. , 2005, Metabolism: clinical and experimental.

[135]  R. Tanzi,et al.  Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective , 2005, Cell.

[136]  R. Langer,et al.  Association between reported alcohol intake and cognition: results from the Women's Health Initiative Memory Study. , 2005, American journal of epidemiology.

[137]  F. Grodstein,et al.  Effects of moderate alcohol consumption on cognitive function in women. , 2005, The New England journal of medicine.

[138]  D. Dexter,et al.  Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease , 2005, Free radical research.

[139]  H. Vainio,et al.  Wine and resveratrol: mechanisms of cancer prevention? , 2003, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[140]  R. Nussbaum,et al.  Alzheimer's disease and Parkinson's disease. , 2003, The New England journal of medicine.

[141]  R. Quirion,et al.  Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide‐related toxicity in cultured hippocampal neurons , 2000, British journal of pharmacology.

[142]  T. Peng,et al.  Mitochondrial dysfunction in Parkinson's disease. , 1999, Biochemical Society symposium.

[143]  D Commenges,et al.  Illustration of analysis taking into account complex survey considerations: the association between wine consumption and dementia in the PAQUID study. Personnes Ages Quid. , 1998, American journal of epidemiology.

[144]  B. Draczynska-Lusiak,et al.  Oxidized lipoproteins activate NF‐κB binding activity and apoptosis in PC12 cells , 1998, Neuroreport.

[145]  C. Sempos,et al.  Alcohol consumption and coronary heart disease morbidity and mortality. , 1997, American journal of epidemiology.

[146]  D. Commenges,et al.  Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. , 1997, Revue neurologique.

[147]  M. Salama,et al.  Effects of Exercise and Ferulic Acid on Alpha Synuclein and Neuroprotective Heat Shock Protein 70 in An Experimental Model of Parkinsonism Disease. , 2019, CNS & neurological disorders drug targets.

[148]  J. Volkmann,et al.  Parkinson disease , 2017, Nature Reviews Disease Primers.

[149]  A. Naeem,et al.  Anti-fibrillation potency of caffeic acid against an antidepressant induced fibrillogenesis of human α-synuclein: Implications for Parkinson's disease. , 2015, Biochimie.

[150]  V. Andrisano,et al.  Surface plasmon resonance, fluorescence, and circular dichroism studies for the characterization of the binding of BACE-1 inhibitors , 2012, Analytical and Bioanalytical Chemistry.

[151]  T. Kihara,et al.  Multifunction of myricetin on A beta: neuroprotection via a conformational change of A beta and reduction of A beta via the interference of secretases. , 2008, Journal of neuroscience research.

[152]  M. Sawada,et al.  Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells. , 2006, Journal of neural transmission. Supplementum.

[153]  L. Letenneur Risk of dementia and alcohol and wine consumption: a review of recent results. , 2004, Biological research.

[154]  E. Seifritz,et al.  Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity. , 2003, Gerontology.

[155]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.